Arthur J. Gallagher & Co. Acquires The John Galt Insurance Agency
Arthur J. Gallagher & Co. Acquires The John Galt Insurance Agency
PR Newswire
ROLLING MEADOWS, Ill., Feb. 5, 2024
ROLLING MEADOWS, Ill., Feb. 5, 2024 /PRNewswire/ -- Arthur J. Gallagher & Co. today announced the acquisition of Fort Lauderdale, Florida-based John Galt Commercial Insurance Agency, LLC and John Galt Insurance Agency, Inc., collectively referred to as The John Galt Insurance Agency. Terms of the transaction were not disclosed.
The John Galt Insurance Agency provides full-service property/casualty insurance coverages with expertise in commercial and multi-family real estate across Florida. Jim Rudd and the John Galt team will remain in their current location under the direction of Bumpy Triche, head of Gallagher's Southeast retail property/casualty brokerage operations.
"The John Galt Insurance Agency's expertise will expand our capabilities in the condominium and association entity real estate niche in Florida," said J. Patrick Gallagher, Jr., Chairman and CEO. "I am delighted to welcome Jim and his associates to Gallagher."
Arthur J. Gallagher & Co. (NYSE:AJG), a global insurance brokerage, risk management and consulting services firm, is headquartered in Rolling Meadows, Illinois. Gallagher provides these services in approximately 130 countries around the world through its owned operations and a network of correspondent brokers and consultants.
Investors: Ray Iardella, VP - Investor Relations | Media: Paul Day, Communications Manager |
630-285-3661/ ray_iardella@ajg.com | 630-285-5946/ paul_day1@ajg.com |
View original content to download multimedia:https://www.prnewswire.com/news-releases/arthur-j-gallagher--co-acquires-the-john-galt-insurance-agency-302051656.html
SOURCE Arthur J. Gallagher & Co.
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
5 Stocks to Buy That We Still Like After They’ve Run Up
-
Markets Brief: Stocks Are Starting to Look Cheap Again
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track
-
American Airlines Earnings: We See Costs Overshadowing Market Share This Year
-
Snap Earnings: Advertising Growth and Snapchat+ Drive Monetization
-
STMicro Earnings: We Still See an Attractive Margin of Safety Despite a Poor First-Half Forecast
-
Alphabet Shares Surge on Strong Earnings, Dividend Surprise
-
Microsoft Earnings: Firm Beats Forecasts on Strong AI and Cloud Demand
-
PG&E Earnings: Near-Term Regulatory Certainty Supports Industry-Leading Earnings Growth